ICCC
Price
$6.39
Change
-$0.00 (-0.00%)
Updated
Jul 3, 02:00 PM (EDT)
Capitalization
57.79M
35 days until earnings call
MYNDF
Price
$0.03
Change
+$0.02 (+200.00%)
Updated
May 20 closing price
Capitalization
2.45M
Interact to see
Advertisement

ICCC vs MYNDF

Header iconICCC vs MYNDF Comparison
Open Charts ICCC vs MYNDFBanner chart's image
ImmuCell
Price$6.39
Change-$0.00 (-0.00%)
Volume$433
Capitalization57.79M
MYND Life Sciences
Price$0.03
Change+$0.02 (+200.00%)
Volume$200
Capitalization2.45M
ICCC vs MYNDF Comparison Chart in %
Loading...
ICCC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MYNDF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ICCC vs. MYNDF commentary
Jul 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ICCC is a Hold and MYNDF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 04, 2025
Stock price -- (ICCC: $6.39 vs. MYNDF: $0.03)
Brand notoriety: ICCC and MYNDF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ICCC: 6% vs. MYNDF: 2%
Market capitalization -- ICCC: $57.79M vs. MYNDF: $2.45M
ICCC [@Biotechnology] is valued at $57.79M. MYNDF’s [@Biotechnology] market capitalization is $2.45M. The market cap for tickers in the [@Biotechnology] industry ranges from $310.37B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ICCC’s FA Score shows that 0 FA rating(s) are green whileMYNDF’s FA Score has 1 green FA rating(s).

  • ICCC’s FA Score: 0 green, 5 red.
  • MYNDF’s FA Score: 1 green, 4 red.
According to our system of comparison, MYNDF is a better buy in the long-term than ICCC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ICCC’s TA Score shows that 3 TA indicator(s) are bullish while MYNDF’s TA Score has 2 bullish TA indicator(s).

  • ICCC’s TA Score: 3 bullish, 5 bearish.
  • MYNDF’s TA Score: 2 bullish, 1 bearish.
According to our system of comparison, MYNDF is a better buy in the short-term than ICCC.

Price Growth

ICCC (@Biotechnology) experienced а -5.82% price change this week, while MYNDF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.93%. For the same industry, the average monthly price growth was +17.38%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

ICCC is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+6.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ICCC($57.8M) has a higher market cap than MYNDF($2.45M). ICCC YTD gains are higher at: 24.175 vs. MYNDF (-48.550). ICCC has higher annual earnings (EBITDA): 2.94M vs. MYNDF (-273.7K). ICCC has more cash in the bank: 4.6M vs. MYNDF (1.81K). MYNDF has less debt than ICCC: MYNDF (3M) vs ICCC (14.7M). ICCC has higher revenues than MYNDF: ICCC (27.3M) vs MYNDF (1).
ICCCMYNDFICCC / MYNDF
Capitalization57.8M2.45M2,356%
EBITDA2.94M-273.7K-1,075%
Gain YTD24.175-48.550-50%
P/E RatioN/AN/A-
Revenue27.3M12,730,000,000%
Total Cash4.6M1.81K254,510%
Total Debt14.7M3M490%
FUNDAMENTALS RATINGS
ICCC: Fundamental Ratings
ICCC
OUTLOOK RATING
1..100
58
VALUATION
overvalued / fair valued / undervalued
1..100
88
Overvalued
PROFIT vs RISK RATING
1..100
77
SMR RATING
1..100
90
PRICE GROWTH RATING
1..100
42
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ICCCMYNDF
RSI
ODDS (%)
Bearish Trend 2 days ago
88%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 2 days ago
48%
Momentum
ODDS (%)
Bullish Trend 2 days ago
79%
N/A
MACD
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
35%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
55%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
79%
Bullish Trend 2 days ago
54%
Advances
ODDS (%)
Bullish Trend 21 days ago
76%
N/A
Declines
ODDS (%)
Bearish Trend 2 days ago
77%
N/A
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
87%
N/A
Aroon
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
71%
View a ticker or compare two or three
Interact to see
Advertisement
ICCC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MYNDF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NN15.930.47
+3.04%
NextNav
STRR1.960.01
+0.51%
Star Equity Holdings Inc.
FNV165.090.65
+0.40%
Franco-Nevada Corp
HAYW14.20-0.14
-0.98%
Hayward Holdings
GAUZ7.49-0.32
-4.16%
Gauzy Ltd

ICCC and

Correlation & Price change

A.I.dvisor indicates that over the last year, ICCC has been loosely correlated with NKTX. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if ICCC jumps, then NKTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ICCC
1D Price
Change %
ICCC100%
+0.08%
NKTX - ICCC
43%
Loosely correlated
+2.34%
BOLT - ICCC
26%
Poorly correlated
+0.17%
JANX - ICCC
24%
Poorly correlated
+5.30%
TRAW - ICCC
24%
Poorly correlated
-0.68%
NERV - ICCC
24%
Poorly correlated
-4.62%
More

MYNDF and

Correlation & Price change

A.I.dvisor tells us that MYNDF and NERV have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MYNDF and NERV's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MYNDF
1D Price
Change %
MYNDF100%
N/A
NERV - MYNDF
29%
Poorly correlated
-4.62%
ICCC - MYNDF
23%
Poorly correlated
+0.08%
CSBR - MYNDF
20%
Poorly correlated
-1.16%
AEON - MYNDF
7%
Poorly correlated
-0.29%
INKT - MYNDF
4%
Poorly correlated
+0.86%
More